Literature DB >> 16805838

High glucose-induced activation of the polyol pathway and changes of gene expression profiles in immortalized adult mouse Schwann cells IMS32.

Kazunori Sango1, Takeshi Suzuki, Hiroko Yanagisawa, Shizuka Takaku, Hiroko Hirooka, Miyuki Tamura, Kazuhiko Watabe.   

Abstract

We investigated the polyol pathway activity and the gene expression profiles in immortalized adult mouse Schwann cells (IMS32) under normal (5.6 mM) and high (30 and 56 mM) glucose conditions for 7-14 days in culture. Messenger RNA and the protein expression of aldose reductase (AR) and the intracellular sorbitol and fructose contents were up-regulated in IMS32 under high glucose conditions compared with normal glucose conditions. By employing DNA microarray and subsequent RT-PCR/northern blot analyses, we observed significant up-regulation of the mRNA expressions for serum amyloid A3 (SAA3), angiopoietin-like 4 (ANGPTL4) and ecotropic viral integration site 3 (Evi3), and the down-regulation of aldehyde reductase (AKR1A4) mRNA expression in the cells under high glucose (30 mM) conditions. The application of an AR inhibitor, SNK-860, to the high glucose medium ameliorated the increased sorbitol and fructose contents and the reduced AKR1A4 mRNA expression, while it had no effect on mRNA expressions for SAA3, ANGPTL4 or Evi3. Considering that the exposure to the high glucose (>or= 30 mM) conditions mimicking hyperglycaemia in vivo accelerated the polyol pathway in IMS32, but not in other previously reported Schwann cells, the culture system of IMS32 under those conditions may provide novel findings about the polyol pathway-related abnormalities in diabetic neuropathy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16805838     DOI: 10.1111/j.1471-4159.2006.03885.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  22 in total

1.  Puerarin may protect against Schwann cell damage induced by glucose fluctuation.

Authors:  Bing Xue; Lin Wang; Zhe Zhang; Rui Wang; Xin-Xin Xia; Ping-Ping Han; Li-Jun Cao; Yong-Hui Liu; Lian-Qing Sun
Journal:  J Nat Med       Date:  2017-02-08       Impact factor: 2.343

2.  Hyperglycemia Promotes Schwann Cell De-differentiation and De-myelination via Sorbitol Accumulation and Igf1 Protein Down-regulation.

Authors:  Wu Hao; Syoichi Tashiro; Tomoka Hasegawa; Yuiko Sato; Tami Kobayashi; Toshimi Tando; Eri Katsuyama; Atsuhiro Fujie; Ryuichi Watanabe; Mayu Morita; Kana Miyamoto; Hideo Morioka; Masaya Nakamura; Morio Matsumoto; Norio Amizuka; Yoshiaki Toyama; Takeshi Miyamoto
Journal:  J Biol Chem       Date:  2015-05-21       Impact factor: 5.157

3.  Hyperglycemia magnifies Schwann cell dysfunction and cell death triggered by PA-induced lipotoxicity.

Authors:  Amelia Padilla; Magda Descorbeth; Audra L Almeyda; Kimberly Payne; Marino De Leon
Journal:  Brain Res       Date:  2010-11-23       Impact factor: 3.252

4.  Protective effects of Salvianolic acid B on Schwann cells apoptosis induced by high glucose.

Authors:  Lian-Qing Sun; Jue Zhao; Ting-Ting Zhang; Ling Qu; Xuan Wang; Bing Xue; Xiao-Jin Li; Yi-Ming Mu; Ju-Ming Lu
Journal:  Neurochem Res       Date:  2012-01-18       Impact factor: 3.996

5.  Global transcriptional programs in peripheral nerve endoneurium and DRG are resistant to the onset of type 1 diabetic neuropathy in Ins2 mice.

Authors:  Anne-Sophie de Preux Charles; Valérie Verdier; Jennifer Zenker; Bastian Peter; Jean-Jacques Médard; Thierry Kuntzer; Jacques S Beckmann; Sven Bergmann; Roman Chrast
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

6.  A brief review of in vitro models of diabetic neuropathy.

Authors:  Namita G Hattangady; Medha S Rajadhyaksha
Journal:  Int J Diabetes Dev Ctries       Date:  2009-10

7.  Glucose-induced metabolic memory in Schwann cells: prevention by PPAR agonists.

Authors:  Esther S Kim; Fumiko Isoda; Irwin Kurland; Charles V Mobbs
Journal:  Endocrinology       Date:  2013-05-24       Impact factor: 4.736

Review 8.  Immortalized adult rodent Schwann cells as in vitro models to study diabetic neuropathy.

Authors:  Kazunori Sango; Hiroko Yanagisawa; Shizuka Takaku; Emiko Kawakami; Kazuhiko Watabe
Journal:  Exp Diabetes Res       Date:  2011-06-13

9.  Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetes.

Authors:  Andrea Cortese; Yi Zhu; Adriana P Rebelo; Sara Negri; Steve Courel; Lisa Abreu; Chelsea J Bacon; Yunhong Bai; Dana M Bis-Brewer; Enrico Bugiardini; Elena Buglo; Matt C Danzi; Shawna M E Feely; Alkyoni Athanasiou-Fragkouli; Nourelhoda A Haridy; Rosario Isasi; Alaa Khan; Matilde Laurà; Stefania Magri; Menelaos Pipis; Chiara Pisciotta; Eric Powell; Alexander M Rossor; Paola Saveri; Janet E Sowden; Stefano Tozza; Jana Vandrovcova; Julia Dallman; Elena Grignani; Enrico Marchioni; Steven S Scherer; Beisha Tang; Zhiqiang Lin; Abdullah Al-Ajmi; Rebecca Schüle; Matthis Synofzik; Thierry Maisonobe; Tanya Stojkovic; Michaela Auer-Grumbach; Mohamed A Abdelhamed; Sherifa A Hamed; Ruxu Zhang; Fiore Manganelli; Lucio Santoro; Franco Taroni; Davide Pareyson; Henry Houlden; David N Herrmann; Mary M Reilly; Michael E Shy; R Grace Zhai; Stephan Zuchner
Journal:  Nat Genet       Date:  2020-05-04       Impact factor: 41.307

10.  Chinese medicine in diabetic peripheral neuropathy: experimental research on nerve repair and regeneration.

Authors:  Yuanlin Piao; Xiaochun Liang
Journal:  Evid Based Complement Alternat Med       Date:  2012-08-15       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.